PF-184563
PF-184563 is a potent, selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich, Kent research center, as a potential treatment for dysmenorrhoea, an indication for which V1a antagonists have shown efficacy.
Wikipage redirect
primaryTopic
PF-184563
PF-184563 is a potent, selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich, Kent research center, as a potential treatment for dysmenorrhoea, an indication for which V1a antagonists have shown efficacy.
has abstract
PF-184563 is a potent, selecti ...... tagonists have shown efficacy.
@en
ATC prefix
Bioavailability
CAS number
748806-39-5
IUPAC name
8-Chloro-5-methyl-1-(3,4,5,6-t ...... 5,10b-tetraaza-benzo[e]azulene
@en
thumbnail
Wikipage page ID
33,175,636
Wikipage revision ID
723,724,334
ChEMBL
ChemSpiderID
elimination half-life
molecular weight
protein bound
smiles
StdInChIKey
LXHAZNJVVVBJIF-UHFFFAOYSA-N
Verifiedfields
verifiedrevid
452,024,825
Watchedfields
hypernym
comment
PF-184563 is a potent, selecti ...... tagonists have shown efficacy.
@en
label
PF-184563
@en
